This study is in progress, not accepting new patients
A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry Disease
Summary
- Eligibility
- for people ages 18-65 (full criteria)
- Location
- at Los Angeles, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Mrinalini Sarkar, MD

Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCLA
- Mrinalini Sarkar, MD
HS Assistant Clinical Professor, Medicine
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Sanofi
- Links
- Sign up for this study
- ID
- NCT05280548
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- About 104 people participating
- Last Updated